The GLP-1-Forecast-Key-Predictions-for-2024

The GLP-1 Forecast: Key Predictions for 2024

04/25/2024 Written by: AP Employee Benefits

Watch the Webinar Replay

AssuredPartners on April 25, discussed how the gene and cell therapy market continues to expand and develop targeted solutions for a wide range of diseases such as cancer, heart disease, and rare hematological conditions. During this session, we explored what actions plan sponsors should consider in order to build a long-term comprehensive management strategy for these therapies.

Watch the recorded webinar below.

Looking for more insights? Contact our Employee Benefits team today.

Contact us

Featured News & Insights

Navigating-Alternative-Benefit-Solutions-for-the-Hourly-Worker
Navigating Alternative Benefit Solutions for the Hourly Worker
Webinar10/01/2025
employee-benefits video

Watch the Webinar Replay Discover how to offer competitive, ACA-compliant benefits to your hourly and variable-hour workforce without the high costs of traditional major medical plans. This webinar...

Supporting-Caregivers-in-the-Workplace-A-Win-Win-for-Employees-Employers
Supporting Caregivers in the Workplace – A Win-Win for Employees & Employers
Webinar09/25/2025
employee-benefits video

Watch the Webinar Replay In this engaging session, we explore how Care for Business is transforming the way organizations support employees with caregiving responsibilities. From finding and...

Dependent-Eligibility-Verification-Audits-Who-What-and-Why-with-Part-D-Advisors
Dependent Eligibility Verification Audits – Who, What and Why with Part D Advisors
Webinar09/18/2025
employee-benefits video

Watch the Webinar Replay Are ineligible dependents draining your health plan budget? Catch the replay of our recent webinar on Dependent Eligibility Verification (DEV) Audits—a critical yet often...